BACKGROUND: The number of hematological malignancies is expected to increase as the Danish population ages within the next few decades. Despite this, data on the course of hematological cancers among the oldest patients are sparse with many intervention studies focusing on younger age groups. The aim of this study is to present Danish incidence and mortality rates among older patients with non-Hodgkin lymphomas (NHL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML). MATERIAL AND METHODS: Nationwide population-based study presenting the incidence, prevalence and mortality rates of NHL, MM, and AML with a focus on the elderly population in Denmark during the last few decades. Data were drawn from the NORDCAN database. RESULTS: Incidence rates of NHL, MM, CLL and AML were 10-50 times higher among the population aged 70 years or more than among the younger population. An increasing incidence with stable or decreased mortality rates was seen mainly among elderly patients with NHL during the last few decades, leading to increased survival and a greater prevalence of patients with NHL. Increased relative survival and prevalence could also be seen among elderly patients with MM and CLL, while the trends of the incidence rates were inconclusive for these diseases. Survival among patients with AML improved most notably in those aged below 70 years leading to an increased prevalence of AML patients predominantly in this age group. CONCLUSION: Improvements in diagnostics and treatment have led to increased survival and therefore prevalence of elderly patients with NHL, MM, CLL and AML during the past decades.
BACKGROUND: The number of hematological malignancies is expected to increase as the Danish population ages within the next few decades. Despite this, data on the course of hematological cancers among the oldest patients are sparse with many intervention studies focusing on younger age groups. The aim of this study is to present Danish incidence and mortality rates among older patients with non-Hodgkin lymphomas (NHL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML). MATERIAL AND METHODS: Nationwide population-based study presenting the incidence, prevalence and mortality rates of NHL, MM, and AML with a focus on the elderly population in Denmark during the last few decades. Data were drawn from the NORDCAN database. RESULTS: Incidence rates of NHL, MM, CLL and AML were 10-50 times higher among the population aged 70 years or more than among the younger population. An increasing incidence with stable or decreased mortality rates was seen mainly among elderly patients with NHL during the last few decades, leading to increased survival and a greater prevalence of patients with NHL. Increased relative survival and prevalence could also be seen among elderly patients with MM and CLL, while the trends of the incidence rates were inconclusive for these diseases. Survival among patients with AML improved most notably in those aged below 70 years leading to an increased prevalence of AMLpatients predominantly in this age group. CONCLUSION: Improvements in diagnostics and treatment have led to increased survival and therefore prevalence of elderly patients with NHL, MM, CLL and AML during the past decades.
Authors: Gabriele Nagel; D Weber; E Fromm; S Erhardt; M Lübbert; W Fiedler; T Kindler; J Krauter; P Brossart; A Kündgen; H R Salih; J Westermann; G Wulf; B Hertenstein; M Wattad; K Götze; D Kraemer; T Heinicke; M Girschikofsky; H G Derigs; H A Horst; C Rudolph; M Heuser; G Göhring; V Teleanu; L Bullinger; F Thol; V I Gaidzik; P Paschka; K Döhner; A Ganser; Hartmut Döhner; R F Schlenk Journal: Ann Hematol Date: 2017-10-31 Impact factor: 3.673
Authors: Tove Wästerlid; Kim Oren Gradel; Sandra Eloranta; Ingrid Glimelius; Tarec C El-Galaly; Henrik Frederiksen; Karin E Smedby Journal: Br J Haematol Date: 2020-11-24 Impact factor: 6.998
Authors: Elizabeth Hubscher; Slaven Sikirica; Timothy Bell; Andrew Brown; Verna Welch; Alexander Russell-Smith; Paul D'Amico Journal: J Cancer Res Clin Oncol Date: 2021-08-30 Impact factor: 4.553
Authors: Jan Vorwerk; Kaiyan Sun; Daria Frank; Felix Neumann; Jana Hüve; Paulina Marie Budde; Longlong Liu; Xiaoqing Xie; Pradeep Kumar Patnana; Helal Mohammed Mohammed Ahmed; Bertram Opalka; Georg Lenz; Ashok Kumar Jayavelu; Cyrus Khandanpour Journal: Front Oncol Date: 2022-08-08 Impact factor: 5.738
Authors: Isabella Capodanno; Mirta Rocchi; Rossella Prandi; Cristina Pedroni; Enrica Tamagnini; Pierluigi Alfieri; Francesco Merli; Luca Ghirotto Journal: Int J Environ Res Public Health Date: 2020-06-05 Impact factor: 3.390